ANGO (AngioDynamics) EPS (Basic) : $-6.03 (TTM As of Aug. 2024)

View and export this data going back to 2004. Start your Free Trial

What is AngioDynamics EPS (Basic)?

AngioDynamics's basic earnings per share (Basic EPS) for the three months ended in Aug. 2024 was $-0.31. Its basic earnings per share (Basic EPS) for the trailing twelve months (TTM) ended in Aug. 2024 was $-6.03.

AngioDynamics's EPS (Diluted) for the three months ended in Aug. 2024 was $-0.31. Its EPS (Diluted) for the trailing twelve months (TTM) ended in Aug. 2024 was $-6.03.

AngioDynamics's EPS without NRI for the three months ended in Aug. 2024 was $-0.11. Its EPS without NRIearnings per share without non-recurring items for the trailing twelve months (TTM) ended in Aug. 2024 was -0.38.

During the past 12 months, AngioDynamics's average EPS without NRIGrowth Rate was -345.20% per year. During the past 3 years, the average EPS without NRI Growth Rate was -2.20% per year. During the past 5 years, the average EPS without NRI Growth Rate was 0.40% per year. Please click Growth Rate Calculation Example (GuruFocus) to see how GuruFocus calculates Wal-Mart Stores Inc (WMT)'s revenue growth rate. You can apply the same method to get the EPS without NRI Growth Rate using EPS without NRI data.

During the past 13 years, AngioDynamics's highest 3-Year average EPS without NRI Growth Rate was 100.00% per year. The lowest was -63.90% per year. And the median was -3.25% per year.

AngioDynamics EPS (Basic) Historical Data

The historical data trend for AngioDynamics's EPS (Basic) can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

AngioDynamics EPS (Basic) Chart

AngioDynamics Annual Data

Trend

May15

May16

May17

May18

May19

May20

May21

May22

May23

May24

EPS (Basic)

Get a 7-Day Free Trial

-4.39

-0.82

-0.68

-1.33

-4.59

AngioDynamics Quarterly Data
	Nov19	Feb20	May20	Aug20	Nov20	Feb21	May21	Aug21	Nov21	Feb22	May22	Aug22	Nov22	Feb23	May23	Aug23	Nov23	Feb24	May24	Aug24
EPS (Basic)	Get a 7-Day Free Trial															1.15	-0.72	-4.67	-0.33	-0.31

AngioDynamics EPS (Basic) Calculation

EPS (Basic) is a rough measurement of the amount of a company's profit that can be allocated to one share of its stock. Basic earnings per share (EPS) do not factor in the dilutive effects on convertible securities.

AngioDynamics's Basic EPS for the fiscal year that ended in May. 2024 is calculated as

Basic EPS (A: May. 2024 )	=	(Net Income	-	Preferred Dividends)	/	Shares Outstanding (Basic Average)
	=	(-184.349	-	0)	/	40.181
	=	-4.59

AngioDynamics's Basic EPS for the quarter that ended in Aug. 2024 is calculated as

Basic EPS (Q: Aug. 2024 )	=	(Net Income	-	Preferred Dividends)	/	Shares Outstanding (Basic Average)
	=	(-12.798	-	0)	/	40.653
	=	-0.31

EPS (Basic) for the trailing twelve months (TTM) ended in Aug. 2024 adds up the quarterly data reported by the company within the most recent 12 months, which was $-6.03

AngioDynamics (NAS:ANGO) EPS (Basic) Explanation

EPS is the single most important variable used by Wall Street in determining the earnings power of a company. But investors need to be aware that Earnings per Share can be easily manipulated by adjusting depreciation and amortization rate or non-recurring items. That's why GuruFocus lists EPS without NRI, which better reflects the company's underlying performance.

Be Aware

Compared with Earnings per share, a company's cash flow is better indicator of the company's earnings power.

If a company's earnings per share is less than cash flow per share over long term, investors need to be cautious and find out why.

AngioDynamics EPS (Basic) Related Terms

Thank you for viewing the detailed overview of AngioDynamics's EPS (Basic) provided by GuruFocus.com. Please click on the following links to see related term pages.

AngioDynamics Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Healthcare » Medical Devices & Instruments » AngioDynamics Inc (NAS:ANGO) » Definitions » EPS (Basic)

Comparable Companies

Traded in Other Exchanges

UG2:Germany UG2:Germany

Address

14 Plaza Drive, Latham, NY, USA, 12110

Website

https://www.angiodynamics.com

AngioDynamics Inc designs manufactures, and sells medical, surgical, and diagnostic devices used by professional healthcare providers for the treatment of peripheral vascular disease and for use in oncology and surgical settings. Geographically, the company derives a majority of its revenue from the United States from sale of Med Tech and Med Device.

Executives

Warren Jr Nighan	officer: SVP Quality and Regulatory	ANGIODYNAMICS, INC., 14 PLAZA DRIVE, LATHAM NY 12110
Stephen A Trowbridge	officer: SVP and General Counsel	14 PLAZA DRIVE, LATHAM NY 120110
James C Clemmer	director, officer: President and CEO	COVIDIEN PLC, 15 HAMPSHIRE STREET, MANSFIELD MA 02048
Lorinda Burgess	director	22 WEST FRONTAG ROAD, NORTHBROOK IL 60093
Karen A Licitra	director	C/O SI-BONE, INC., 471 EL CAMINO REAL, SUITE 101, SANTA CLARA CA 95050
Michael E Tarnoff	director	C/O ANGIODYNAMICS, INC., 14 PLAZA DRIVE, LATHAM NY 12110
Scott Centea	officer: SVP/GM, VIT	C/O ANGIODYNAMICS, INC., 14 PLAZA DRIVE, LATHAM NY 12110
Dave Helsel	officer: SVP Global Operations and R&D	400 WOOD ROAD, BRAINTREE MA 02184
Laura Piccinini	officer: SVP International	C/O ANGIODYNAMICS INC., 14 PLAZA DRIVE, LATHAM NY 12110
Wesley Johnson	director
Chad Thomas Campbell	officer: SVP/GM, Vascular Access	140 POKANOKET PATH, WRENTHAM MA 02093
Richard C Rosenzweig	officer: SVP and General Counsel	C/O DENTSPLY SIRONA INC., 13320 BALLANTYNE CORPORATE PLACE, CHARLOTTE NC 28277
Kevin J Gould	director	247 WASHINGTON STREET, DUXBURY MA 02332
Brent J. Boucher	officer: SVP and GM of Oncology	14 PLAZA DRIVE, LATHAM NY 12110
Michael Greiner	officer: EVP and CFO	C/O VISTAPRINT, 95 HAYDEN AVENUE, LEXINGTON MA 02421